SCHEMBL2708376

SCHEMBL2708376

CC=C/[C]=C/CC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27527394 0.97
SCHEMBL18420879 0.75
SCHEMBL4663625 0.73
SCHEMBL17866117 0.73
SCHEMBL17866116 0.73
SCHEMBL28549828 0.73
SCHEMBL5304841 0.69
SCHEMBL1481934 0.69
SCHEMBL833661 0.65
SCHEMBL833660 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160184340-A1 THE USE OF SPINOSYNS AND SPINOSYN COMPOSITIONS AS LOCAL ANESTHETICS AND AS ANTIARRHYTHMIC AGENTS KRITIKOU, CHRISTINE (ONE-THIRD INTEREST) (GR) 2016-06-30 US disclosed
EP-2445506-A1 THE USE OF SPINOSYNS AND SPINOSYN COMPOSITIONS AGAINST DISEASES CAUSED BY PROTOZOANS, VIRAL INFECTIONS AND CANCER Entarco SA (GR) 2012-05-02 EP disclosed
WO-2010150100-A1 THE USE OF SPINOSYNS AND SPINOSYN COMPOSITIONS AGAINST DISEASES CAUSED BY PROTOZOANS, VIRAL INFECTIONS AND CANCER ENTARCO SA (GR) 2010-12-29 WO disclosed
EP-1423355-A1 BRIDGED P-PHENYLENEDIAMINES Henkel Kommanditgesellschaft auf Aktien (DE) 2004-06-02 EP disclosed
WO-2003024917-A1 BRIDGED P-PHENYLENEDIAMINES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2003-03-27 WO disclosed